We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
-0.11%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$357M
AUM Growth
-$43.8M
Cap. Flow
-$31.5M
Cap. Flow %
-8.82%
Top 10 Hldgs %
26.98%
Holding
360
New
86
Increased
29
Reduced
54
Closed
99

Top Sells

Rank Stock Value
1
TASK icon
TaskUs
TASK
+$8.12M
2
T icon
AT&T
T
+$6.09M
3
SONY icon
Sony
SONY
+$5.84M
4
ZIP icon
ZipRecruiter
ZIP
+$3.81M
5
EQC
Equity Commonwealth
EQC
+$3.79M

Sector Composition

Rank Sector Weight
1 Financials 24.45%
2 Healthcare 9.51%
3 Communication Services 8.7%
4 Industrials 7.33%
5 Technology 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODT
201
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$262K 0.07%
+89,974
New +$299K
SKIN icon
202
SkinHealth Systems
SKIN
$94.9M
$260K 0.07%
+10,000
New +$220K
KCGI.U
203
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$255K 0.07%
+25,000
New +$253K
CLNE icon
204
CALL
Clean Energy Fuels
CLNE
$447M
$245K 0.07%
+30,000
New +$239K
ORGNW
205
DELISTED
Origin Materials Inc Warrants
ORGNW
$241K 0.07%
153,459
+3,459
+2% +$5.7K
RKLY.WS
206
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$239K 0.07%
+100,000
New +$224K
PHLT
207
DELISTED
Performant Healthcare Inc
PHLT
$238K 0.07%
60,000
+41,600
+226% +$184K
HCAQ
208
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$237K 0.07%
23,900
-2,100
-8% -$20.8K
JXN icon
209
Jackson Financial
JXN
$8.32B
$234K 0.07%
+9,000
New +$245K
ENVXW
210
DELISTED
Enovix Corporation Warrant
ENVXW
$227K 0.06%
26,000
+11,716
+82% +$82.7K
BNED icon
211
Barnes & Noble Education
BNED
$412M
$218K 0.06%
218
-1,022
-82% -$901K
MTTRW
212
DELISTED
Matterport, Inc. Warrant
MTTRW
$218K 0.06%
28,000
+3,000
+12% +$19K
KPLT icon
213
Katapult Holdings
KPLT
$32.8M
$217K 0.06%
+1,600
New +$278K
JRSH icon
214
Jerash Holdings
JRSH
$58.8M
$202K 0.06%
+30,000
New +$225K
CAS.U
215
DELISTED
Cascade Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half o
CAS.U
$201K 0.06%
20,000
GTPBU
216
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$200K 0.06%
20,000
LUXA
217
CALL
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$196K 0.05%
20,000
BMTX.WS
218
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$174K 0.05%
116,870
CCXI
219
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$171K 0.05%
+10,000
New +$156K
HUT
220
Hut 8
HUT
$12.4B
$168K 0.05%
+4,000
New +$133K
MTBL
221
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$168K 0.05%
120,450
-141,370
-54% -$157K
NOACW
222
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$163K 0.05%
320,360
-43,000
-12% -$26.3K
CND
223
DELISTED
Concord Acquisition Corp.
CND
$160K 0.04%
+15,879
New +$163K
ORGN
224
DELISTED
Origin Materials
ORGN
$136K 0.04%
667
-3,782
-85% -$779K
LSEA
225
DELISTED
Landsea Homes
LSEA
$132K 0.04%
15,291
-80,558
-84% -$691K

Similar funds

MYDA Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, MYDA Advisors held 360 positions worth $357M, down 11% from $401M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

MYDA Advisors withdrew a net $31.5M in Q3 2021, closing 99 positions and reducing 54 holdings. Its most notable exit was TaskUs, an estimated $8.12M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, MYDA Advisors opened a new position in Stevanato worth $3.29M.

  • MYDA Advisors's largest Q3 2021 buy was Stevanato: 130,000 shares worth $3.29M.
  • MYDA Advisors added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $4.16M increase.
  • MYDA Advisors's biggest Q3 2021 reduction was AT&T, cutting an estimated $6.09M.
  • MYDA Advisors fully exited TaskUs in Q3 2021, selling an estimated $8.12M.
  • MYDA Advisors's ten largest holdings make up 27% of its $357M portfolio in Q3 2021.
  • MYDA Advisors opened 86 new positions and closed 99 in Q3 2021.
  • MYDA Advisors's portfolio value fell 11% quarter-over-quarter to $357M.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.